Skip to main content
TipRanks
Go Ultimate75% OFF

GlaxoSmithKline (GSK) Financial Statements

1,178 Followers

GlaxoSmithKline Financial Overview

GlaxoSmithKline's market cap is currently £73.24B. The company's EPS TTM is £1.08; its P/E ratio is 17.06; and it has a dividend yield of 3.74%. GlaxoSmithKline is estimated to report earnings on February 3, 2027, and the estimated EPS forecast is £0.28. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue£ 32.67B£ 31.38B£ 30.33B£ 29.32B£ 24.70B
Gross Profit£ 23.70B£ 21.90B£ 21.25B£ 19.46B£ 16.34B
Operating Income£ 7.17B£ 5.66B£ 6.99B£ 6.68B£ 5.41B
EBITDA£ 11.88B£ 6.67B£ 9.14B£ 8.63B£ 6.45B
Net Income£ 5.72B£ 2.58B£ 4.93B£ 14.96B£ 4.38B
Balance Sheet
Cash & Short-Term Investments£ 3.16B£ 3.71B£ 5.69B£ 7.68B£ 4.13B
Total Assets£ 61.12B£ 59.46B£ 59.01B£ 60.15B£ 79.10B
Total Debt£ 17.72B£ 16.99B£ 18.02B£ 20.99B£ 24.17B
Net Debt£ 14.57B£ 13.29B£ 15.08B£ 17.46B£ 20.10B
Total Liabilities£ 45.16B£ 46.38B£ 46.21B£ 50.05B£ 57.76B
Stockholders' Equity£ 16.38B£ 13.67B£ 13.35B£ 10.60B£ 15.05B
Cash Flow
Free Cash Flow£ 5.96B£ 3.57B£ 4.42B£ 5.14B£ 5.02B
Operating Cash Flow£ 7.30B£ 6.55B£ 6.77B£ 7.40B£ 7.95B
Investing Cash Flow£ -5.85B£ -1.23B£ -1.59B£ -8.77B£ -1.78B
Financing Cash Flow£ -1.63B£ -4.73B£ -5.64B£ 823.00M£ -7.59B

Currency in GBP

GlaxoSmithKline Earnings and Revenue History

012B24B36B0 %20 %40 %60 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin

GlaxoSmithKline Liabilities to Assets

030B60B90B70 %80 %90 %100 %LiabilitiesLiabilities to Assets201720182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

GlaxoSmithKline Cash Flow

-15B-10B-5B05B10B201720182019202020212022202320242025OperatingInvestingFinancing

GlaxoSmithKline Forecast EPS vs Actual EPS

0.20.30.40.50.6Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss